TFEB Modulates p21/WAF1/CIP1 during the DNA Damage Response

The MiT/TFE family of transcription factors (MITF, TFE3, and TFEB), which control transcriptional programs for autophagy and lysosome biogenesis have emerged as regulators of energy metabolism in cancer. Thus, their activation increases lysosomal catabolic function to sustain cancer cell growth and...

Full description

Saved in:
Bibliographic Details
Published inCells (Basel, Switzerland) Vol. 9; no. 5; p. 1186
Main Authors Pisonero-Vaquero, Sandra, Soldati, Chiara, Cesana, Marcella, Ballabio, Andrea, Medina, Diego Luis
Format Journal Article
LanguageEnglish
Published Switzerland MDPI 10.05.2020
MDPI AG
Subjects
autophagy
Basic Helix-Loop-Helix Leucine Zipper Transcription Factors - metabolism
cancer
cell cycle
Cell Survival
Cyclin-Dependent Kinase Inhibitor p21 - genetics
Cyclin-Dependent Kinase Inhibitor p21 - metabolism
DNA Damage - genetics
DNA-damage response
G2 Phase
Gene Expression Regulation
HeLa Cells
Humans
Mitosis
p21
TFEB
Transcription, Genetic
Tumor Suppressor Protein p53 - metabolism
autophagy
cell cycle
TFEB
DNA-damage response
genotoxic stress
cancer
doxorubicin
p21
Online AccessGet full text

Cover

More Information
Summary:The MiT/TFE family of transcription factors (MITF, TFE3, and TFEB), which control transcriptional programs for autophagy and lysosome biogenesis have emerged as regulators of energy metabolism in cancer. Thus, their activation increases lysosomal catabolic function to sustain cancer cell growth and survival in stress conditions. Here, we found that TFEB depletion dramatically reduces basal expression levels of the cyclin-dependent kinase (CDK) inhibitor p21/WAF1 in various cell types. Conversely, TFEB overexpression increases p21 in a p53-dependent manner. Furthermore, induction of DNA damage using doxorubicin induces TFEB-mediated activation of p21, delays G2/M phase arrest, and promotes cell survival. Pharmacological inhibition of p21, instead, abrogates TFEB-mediated protection during the DNA damage response. Together, our findings uncover a novel and direct role of TFEB in the regulation of p21 expression in both steady-state conditions and during the induction of DNA-damage response (DDR). Our observations might open novel therapeutic strategies to promote cancer cell death by targeting the TFEB-p21 pathway in the presence of genotoxic agents.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
These authors contributed equally to this work.
ISSN:2073-4409
2073-4409
DOI:10.3390/cells9051186